Acute over-the-counter pharmacological intervention does not adversely affect behavioral outcome following diffuse traumatic brain injury in the mouse

Experimental Brain Research

Volumn 232, Issue 9, 2014, Pages 2709-2719

  Harrison, Jordan L ^a,b,c   Rowe, Rachel K ^a,b,d   O'Hara, Bruce F ^d,e   Adelson, P David ^a,b,c   Lifshitz, Jonathan ^a,b,c,f  

^a PHOENIX CHILDREN'S HOSPITAL   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c ARIZONA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

^e UNIVERSITY OF KENTUCKY   (United States)

^f Research Service   (United States)

Author keywords

Analgesic; Inflammation; Mouse; NSAID; Sleep; TBI

Indexed keywords

ALCOHOL; GAMMA INTERFERON; IBUPROFEN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; NON PRESCRIPTION DRUG; PARACETAMOL; TUMOR NECROSIS FACTOR ALPHA; ANESTHETIC AGENT; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN CORTEX; BRAIN FUNCTION; CONCUSSION; CONTROLLED STUDY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HOME CARE; INFLAMMATION; LATENT PERIOD; MALE; MIDLINE FLUID PERCUSSION INJURY; MOTOR PERFORMANCE; MOUSE; NEUROLOGICAL SEVERITY SCORE; NONHUMAN; OUTCOME ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; RIGHTING REFLEX; ROTAROD TEST; SCORING SYSTEM; TRAUMATIC BRAIN INJURY; TREATMENT OUTCOME; ANALYSIS OF VARIANCE; ANIMAL; BRAIN INJURIES; C57BL MOUSE; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; METABOLISM; MOTOR ACTIVITY; NERVOUS SYSTEM DISEASES; NEUROLOGIC EXAMINATION; TIME;

ANALYSIS OF VARIANCE; ANESTHETICS; ANIMALS; BRAIN INJURIES; CYTOKINES; DISEASE MODELS, ANIMAL; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; NERVOUS SYSTEM DISEASES; NEUROLOGIC EXAMINATION; NONPRESCRIPTION DRUGS; ROTAROD PERFORMANCE TEST; TIME FACTORS;

EID: 84906259016     PISSN: 00144819     EISSN: 14321106     Source Type: Journal    
DOI: 10.1007/s00221-014-3948-3     Document Type: Article

References (42)

1. Allan SM, Rothwell NJ (2001) Cytokines and acute neurodegeneration. Nat Rev Neurosci 2:734-744. doi:10.1038/35094583 (Pubitemid 33674819)
2. Bachstetter AD, Rowe RK, Kaneko M, Goulding D, Lifshitz J, Van Eldik LJ (2013) The p38alpha MAPK regulates microglial responsiveness to diffuse traumatic brain injury. J Neurosci 33:6143-6153
3. Banchereau J, Pascual V, O'Garra A (2012) From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines. Nat Immunol 13:925-931. doi:10.1038/ni.2406
4. Browne KD, Iwata A, Putt ME, Smith DH (2006) Chronic ibuprofen administration worsens cognitive outcome following traumatic brain injury in rats. Exp Neurol 201:301-307 (Pubitemid 44344222)
5. Cao T, Thomas TC, Ziebell JM, Pauly JR, Lifshitz J (2012) Morphological and genetic activation of microglia after diffuse traumatic brain injury in the rat. Neuroscience 225:65-75
6. Chen Y, Constantini S, Trembovler V, Weinstock M, Shohami E (1996) An experimental model of closed head injury in mice: pathophysiology, histopathology, and cognitive deficits. J Neurotrauma 13:557-568 (Pubitemid 26377854)
7. Chio CC, Chang CH, Wang CC et al (2013) Etanercept attenuates traumatic brain injury in rats by reducing early microglial expression of tumor necrosis factor-alpha. BMC Neurosci 14:33
8. Dani M, Guindon J, Lambert C, Beaulieu P (2007) The local antinociceptive effects of paracetamol in neuropathic pain are mediated by cannabinoid receptors. Eur J Pharmacol 573:214-215. doi:10.1016/j.ejphar.2007.07.012 (Pubitemid 47464223)
9. Dash PK, Mach SA, Moore AN (2000) Regional expression and role of cyclooxygenase-2 following experimental traumatic brain injury. J Neurotrauma 17:69-81 (Pubitemid 30075617)
10. Faul M, Xu L, Wald MM, Coronado VG (2010) In: Centers for disease control and prevention NCfIPaC (ed) Traumatic brain injury in the United States: emergency department visits, hospitalizations and deaths 2002-2006. Atlanta, GA
11. Frugier T, Morganti-Kossmann MC, O'Reilly D, McLean CA (2010) In situ detection of inflammatory mediators in post mortem human brain tissue after traumatic injury. J Neurotrauma 27:497-507
12. Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448-454 (Pubitemid 29084777)
13. Gatson JW, Liu MM, Abdelfattah K, Wigginton JG, Smith S, Wolf S, Minei JP (2013) Resveratrol decreases inflammation in the brain of mice with mild traumatic brain injury. J Trauma Acute Care Surg 74:470-474; discussion 474-475
14. Gopez JJ, Yue H, Vasudevan R et al (2005) Cyclooxygenase-2-specific inhibitor improves functional outcomes, provides neuroprotection, and reduces inflammation in a rat model of traumatic brain injury. Neurosurgery 56:590-604
15. Hosseini AH, Lifshitz J (2009) Brain injury forces of moderate magnitude elicit the fencing response. Med Sci Sports Exerc 41:1687-1697
16. Langlois JA, Rutland-Brown W, Wald MM (2006) The epidemiology and impact of traumatic brain injury: a brief overview. J Head Trauma Rehabil 21:375-378 (Pubitemid 44413110)
17. Lifshitz J (2008) Fluid percussion injury In: Chen J, Xu X-M, Zhang J (eds) Animal models of acute neurological injuries. The Humana Press Inc., Totowa, NJ
18. Lloyd E, Somera-Molina K, Van Eldik LJ, Watterson DM, Wainwright MS (2008) Suppression of acute proinflammatory cytokine and chemokine upregulation by post-injury administration of a novel small molecule improves long-term neurologic outcome in a mouse model of traumatic brain injury. J Neuroinflammation 5:28
19. Maiese K (2008) Head injuries: diagnosis and treatment. In: The merck manual home health handbook, vol 2013. Merck Sharp & Dohme Corp., Whitehouse Station, NJ
20. Morganti-Kossmann MC, Rancan M, Otto VI, Stahel PF, Kossmann T (2001) Role of cerebral inflammation after traumatic brain injury: a revisited concept. Shock 16:165-177 (Pubitemid 33598193)
21. Morganti-Kossmann MC, Rancan M, Stahel PF, Kossmann T (2002) Inflammatory response in acute traumatic brain injury: a double-edged sword. Curr Opin Crit Care 8:101-105 (Pubitemid 36132681)
22. Ng SY, Semple BD, Morganti-Kossmann MC, Bye N (2012) Attenuation of microglial activation with minocycline is not associated with changes in neurogenesis after focal traumatic brain injury in adult mice. J Neurotrauma 29:1410-1425
23. Ottani A, Leone S, Sandrini M, Ferrari A, Bertolini A (2006) The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors. Eur J Pharmacol 531:280-281. doi:10.1016/j.ejphar.2005.12.015 (Pubitemid 43202247)
24. Pleasant JM, Carlson SW, Mao H, Scheff SW, Yang KH, Saatman KE (2011) Rate of neurodegeneration in the mouse controlled cortical impact model is influenced by impactor tip shape: implications for mechanistic and therapeutic studies. J Neurotrauma 28:2245-2262
25. Prins M, Greco T, Alexander D, Giza CC (2013) The pathophysiology of traumatic brain injury at a glance. Dis Model Mech 6:1307-1315
26. Reagan-Shaw S, Nihal M, Ahmad N (2008) Dose translation from animal to human studies revisited. FASEB J 22:659-661 (Pubitemid 351348146)
27. Reilly P (2007) The impact of neurotrauma on society: an international perspective. Prog Brain Res 161:3-9. doi:10.1016/S0079-6123(06)61001-7
28. Roozenbeek B, Maas AI, Menon DK (2013) Changing patterns in the epidemiology of traumatic brain injury. Nat Rev Neurol 9:231-236
29. Rowe RK, Harrison JL, Thomas TC, Pauly JR, Adelson PD, Lifshitz J (2013) Using anesthetics and analgesics in experimental traumatic brain injury. Lab Anim (NY) 42:286-291
30. Rowe RK, Harrison JL, O'Hara BF, Lifshitz J (2014a) Recovery of neurological function despite immediate sleep disruption following diffuse brain injury in the mouse: clinical relevance to medically untreated concussion sleep. Sleep 37:743-752
31. Rowe RK, Striz M, Bachstetter AD, Van Eldik LJ, Donohue KD, O'Hara BF, Lifshitz J (2014b) Diffuse brain injury induces acute post-traumatic sleep. PLoS ONE 9:e82507. doi:10.1371/journal.pone.0082507
32. Schmidt OI, Heyde CE, Ertel W, Stahel PF (2005) Closed head injury - an inflammatory disease? Brain Res Brain Res Rev 48:388-399 (Pubitemid 40585769)
33. Semple BD, Bye N, Rancan M, Ziebell JM, Morganti-Kossmann MC (2010) Role of CL2 (MCP-1) in traumatic brain injury (TBI): evidence from severe TBI patients and CL2-/- mice. J Cereb Blood Flow Metab 30:769-782
34. Setnik L, Bazarian JJ (2007) The characteristics of patients who do not seek medical treatment for traumatic brain injury. Brain Inj 21:1-9 (Pubitemid 46957668)
35. Thau-Zuchman O, Shohami E, Alexandrovich AG, Trembovler V, Leker RR (2012) The anti-inflammatory drug carprofen improves long-term outcome and induces gliogenesis after traumatic brain injury. J Neurotrauma 29:375-384
36. Theeler B, Lucas S, Riechers RG 2nd, Ruff RL (2013) Post-traumatic headaches in civilians and military personnel: a comparative, clinical review. Headache 53:881-900. doi:10.1111/head.12123
37. Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 231:232-235
38. Wang KK, Larner SF, Robinson G, Hayes RL (2006) Neuroprotection targets after traumatic brain injury. Curr Opin Neurol 19:514-519 (Pubitemid 44760432)
39. Werner C, Engelhard K (2007) Pathophysiology of traumatic brain injury. Br J Anaesth 99:4-9. doi:10.1093/bja/aem131 (Pubitemid 47072553)
40. Woodcock T, Morganti-Kossmann MC (2013) The role of markers of inflammation in traumatic brain injury. Front Neurol 4:18. doi:10.3389/fneur. 2013.00018
41. Ziebell JM, Morganti-Kossmann MC (2010) Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. Neurotherapeutics 7:22-30
42. Ziebell JM, Bye N, Semple BD, Kossmann T, Morganti-Kossmann MC (2011) Attenuated neurological deficit, cell death and lesion volume in Fas-mutant mice is associated with altered neuroinflammation following traumatic brain injury. Brain Res 1414:94-105